Patents by Inventor Marie Chantal Siu-Ying Tran

Marie Chantal Siu-Ying Tran has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2,5-disubstituted arylsulfonamide CCR3 antagonists
    Patent number: 8669247
    Abstract: Provided herein are 2,5-disubstituted arylsulfonamides that are useful for modulating CCR3 activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3-mediated disorder, disease, or condition.
    Type: Grant
    Filed: March 18, 2013
    Date of Patent: March 11, 2014
    Assignee: Axikin Pharmaceuticals, Inc.
    Inventors: Tai Wei Ly, Marie Chantal Siu-Ying Tran, Erik Dean Raaum
  • 2,5-DISUBSTITUTED ARYLSULFONAMIDE CCR3 ANTAGONISTS
    Publication number: 20130225565
    Abstract: Provided herein are 2,5-disubstituted arylsulfonamides that are useful for modulating CCR3 activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3-mediated disorder, disease, or condition.
    Type: Application
    Filed: March 18, 2013
    Publication date: August 29, 2013
    Applicant: Axikin Pharmaceuticals, Inc.
    Inventors: Tai Wei LY, Marie Chantal Siu-Ying TRAN, Erik Dean RAAUM
  • 2,5-disubstituted arylsulfonamide CCR3 antagonists
    Patent number: 8399456
    Abstract: Provided herein are 2,5-disubstituted arylsulfonamides that are useful for modulating CCR3 activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3-mediated disorder, disease, or condition.
    Type: Grant
    Filed: April 21, 2010
    Date of Patent: March 19, 2013
    Assignee: Axikin Pharmaceuticals, Inc.
    Inventors: Tai Wei Ly, Marie Chantal Siu-Ying Tran, Erik Dean Raaum
  • Alkylthio pyrimidines as CRTH2 antagonists
    Patent number: 8324229
    Abstract: Provided herein are alkylthio substituted pyrimidine compounds having CRTH2 (G-protein-coupled chemoattractant receptor, expressed on Th2 cells) antagonistic activity, useful for the treatment or prophylaxis of diseases associated with CRTH2 activity, including the treatment of allergic diseases, eosinophil-related diseases and basophil-related diseases.
    Type: Grant
    Filed: September 24, 2008
    Date of Patent: December 4, 2012
    Assignee: Actimis Pharmaceuticals, Inc.
    Inventors: Tai Wei Ly, Erik Dean Raaum, Marie Chantal Siu-Ying Tran
  • 2-S-benzyl substituted pyrimidines as CRTH2 antagonists
    Patent number: 8314116
    Abstract: Provided herein are 2-S-benzyl pyrimidine compounds having CRTH2 (G-protein-coupled chemoattractant receptor, expressed on Th2 cells) antagonistic activity, useful for the prophylaxis and treatment of diseases associated with CRTH2 activity, including the treatment of allergic diseases, eosinophil-related diseases and basophil-related diseases.
    Type: Grant
    Filed: September 24, 2008
    Date of Patent: November 20, 2012
    Assignee: Actimis Pharmaceuticals, Inc.
    Inventors: Tai Wei Ly, Garrett Thomas Potter, Marie Chantal Siu-Ying Tran
  • 2,5-DISUBSTITUTED ARYLSULFONAMIDE CCR3 ANTAGONISTS
    Publication number: 20100273782
    Abstract: Provided herein are 2,5-disubstituted arylsulfonamides that are useful for modulating CCR3 activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3-mediated disorder, disease, or condition.
    Type: Application
    Filed: April 21, 2010
    Publication date: October 28, 2010
    Applicant: Axikin Pharmaceuticals, Inc.
    Inventors: Tai Wei Ly, Marie Chantal Siu-Ying Tran, Erik Dean Baaum
  • 2-S-Benzyl Substituted Pyrimidines As CRTH2 Antagonists
    Publication number: 20100240685
    Abstract: Provided herein are 2-S-benzyl pyrimidine compounds having CRTH2 (G-protein-coupled chemoattractant receptor, expressed on Th2 cells) antagonistic activity, useful for the prophylaxis and treatment of diseases associated with CRTH2 activity, including the treatment of allergic diseases, eosinophil-related diseases and basophil-related diseases.
    Type: Application
    Filed: September 24, 2008
    Publication date: September 23, 2010
    Inventors: Tai Wei Ly, Garnett Thomas Potter, Marie Chantal Siu-Ying Tran